Johnson Pharmacare Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | TBA | -0.33 | TBA |
| Operating Expense | 0.05 | 0.18 | 0.03 |
| Net Profit | -0.05 | -0.51 | -0.03 |
| Net Profit Margin | TBA | 154.55 | TBA |
| Earning Per Share | TBA | -0.01 | TBA |
| EBIDTA | -0.05 | -0.51 | -0.03 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | TBA |
| Operating Expense | 0.05 |
| Net Profit | -0.05 |
| Net Profit Margin | TBA |
| Earning Per Share | TBA |
| EBIDTA | -0.05 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | 2.53 |
| Operating Expenses Annual | 0.58 | 0.20 | 3.86 |
| Operating Profit Annual | -0.58 | -0.20 | -1.33 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | TBA | TBA | TBA |
| Net Profit Annual | -0.58 | -0.20 | -1.29 |
| Tax Annual | TBA | TBA | -0.04 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.58 |
| Operating Profit Annual | -0.58 |
| Interest Annual | TBA |
| Depreciation | TBA |
| Net Profit Annual | -0.58 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | TBA | TBA | 0.04 |
| Cash Flow from Operations | -1.91 | -0.05 | -0.40 |
| Cash Flow from Investing | 3.27 | TBA | -0.94 |
| Cash Flow from Financing | -1.35 | 0.05 | 1.30 |
| Cash Flow at the End | 0.01 | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | TBA |
| Cash Flow from Operations | -1.91 |
| Cash Flow from Investing | 3.27 |
| Cash Flow from Financing | -1.35 |
| Cash Flow at the End | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | 8.70 |
| PBIT Margin (%) | TBA | TBA | 8.70 |
| PBT Margin (%) | TBA | TBA | 8.70 |
| Net PROFIT Margin (%) | TBA | TBA | -50.99 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | TBA | TBA | -2.04 |
| Total Debt / Equity (X) | 0.02 | 0.03 | 0.02 |
| Asset Turnover Ratio (%) | TBA | TBA | 0.04 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | 0.02 |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | TBA | TBA | TBA |
| Total Current Assets Annual | 1.36 | 0.00 | 0.00 |
| Non Current Assets Annual | 56.56 | 59.83 | 59.83 |
| Total Shareholders Funds Annual | 56.17 | 56.75 | 56.95 |
| Total Assets Annual | 57.93 | 59.83 | 59.83 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | TBA |
| Total Current Assets Annual | 1.36 |
| Non Current Assets Annual | 56.56 |
| Total Shareholders Funds Annual | 56.17 |
| Total Assets Annual | 57.93 |
No Data Availabe
